MA

Mohammadhyder Amirhyder Jaidi

Active Director Designated Partner DIN 09459220
DIN 09459220 First appointment Jan 2022 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohammadhyder Amirhyder Jaidi

Data last updated:

Mohammadhyder Amirhyder Jaidi is a Designated Partner at Tenx Pharma Llp (since 2022). The company operates in Business Services.

DIN 09459220
Primary Designation Designated Partner
Industry Business Services
First Appointment 06 Jan 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Tenx Pharma Llp ABA-1345
Designated Partner06 Jan 20222022Active

Board colleagues of Mohammadhyder Amirhyder Jaidi

NameDINCompanyDesignation
Nihalhyder Amirhyder Jaidi09459219Tenx Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Tenx Pharma Llp
Premium access

Shareholding and investment profile for Mohammadhyder Amirhyder Jaidi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammadhyder Amirhyder Jaidi

Mohammadhyder Amirhyder Jaidi currently holds 1 directorship: Tenx Pharma Llp (Designated Partner, since 06 Jan 2022).

Mohammadhyder Amirhyder Jaidi was first appointed on 06 Jan 2022 as Designated Partner at Tenx Pharma Llp.

The current boards of Mohammadhyder Amirhyder Jaidi's companies include Nihalhyder Amirhyder Jaidi (Tenx Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available